Simecrin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Simecrin

Property Description
Active ingredient Simethicone
Form Oral drops/suspension, capsule, chewable tablet
Pharmacological class Gastrointestinal agent (Antiflatulent)
Common use Relieving gas, bloating, and abdominal discomfort
Origin Synthetic, silicone-based polymer

What Type of Medicine is Simecrin and What is Its Purpose?

Simecrin is a designated gastrointestinal agent classified as an antiflatulent, whose primary purpose is the rapid relief of discomfort caused by excessive trapped gas in the digestive tract. The medicine’s core functionality centers on its active compound, Simethicone, which is an inert, physically acting substance. Simethicone functions as a defoaming agent and is categorized under the pharmacological class of surface-active agents. The use of Simethicone for gas relief is clinically recognized and supported by pharmacological studies. This means the medicine physically helps break up gas in the gut. Its unique, localized action is essential to its general therapeutic purpose, which is focused solely on managing physical gas accumulation and the resultant feelings of abdominal pressure, fullness, and bloating without altering systemic bodily processes.


Simethicone Composition: Synthetic Origin and Available Forms

The active ingredient, Simethicone, is a synthetic, silicone-based compound chemically constituted as a mixture of activated polydimethylsiloxane and silicon dioxide. As a synthetic compound, its structure is engineered to be effective at low concentrations and is deliberately non-absorbable by the body's intestinal lining. This critical attribute ensures that the compound acts exclusively on the gas within the gut lumen and is excreted unchanged. The drug's physical mechanism of decreasing the surface tension of gas bubbles is the contributor to its therapeutic efficacy. This means the medicine works by collapsing the bubbles, not by systemic means. Simecrin, like other preparations containing Simethicone, is widely available as an over-the-counter (OTC) option, typically administered via the oral route and formulated as liquid suspensions (such as drops or emulsions), soft-gel capsules, or chewable tablets.

Regulatory References

  1. MedlinePlus Drug Information on Simethicone
  2. Simethicone: Drug Information

What side effects are possible with Simecrin?

Possible side effects and safety information

The safety profile of Simecrin (Simethicone) is shaped by its mechanism as a physically acting agent that is not absorbed into the bloodstream. This property means that systemic adverse effects are not anticipated, as noted in official regulatory documents.

Documented Adverse Reactions and Frequency

Adverse reactions listed in regulatory safety information, typically based on post-marketing surveillance, fall into two main categories: minor gastrointestinal disturbances and rare immune system reactions. The frequency of most effects is classified as Not known or Rarely reported.

System-Organ Class Documented Adverse Reactions
Gastro-Intestinal Disorders Nausea, Vomiting, Constipation
Immune System/Skin Disorders Hypersensitivity reactions (Rare)

Serious Safety Considerations

The most serious adverse reactions documented are rare hypersensitivity reactions to the active substance or excipients, which are classified within the Immune System and Skin Disorders. These reactions may include manifestations such as rash, pruritis, facial oedema, tongue oedema, and difficulty breathing (dyspnoea). These events represent the highest level of caution documented in regulatory labeling.

Safety Constraints and Special Populations

Official labels list hypersensitivity to any product ingredient as a contraindication for use. For Pregnancy and Lactation, adverse effects are not anticipated because Simethicone lacks systemic exposure. However, some regulatory bodies have stated that the medicine is not recommended for the treatment of infant colic due to a lack of sufficient safety and efficacy data specifically for that population.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Simecrin (Simethicone) is strictly defined by its physiologically inert nature. As a non-absorbed compound, authoritative regulatory documents emphasize that the medicine does not enter the systemic circulation. Consequently, an overdose is considered unlikely to result in specific systemic toxic effects or severe, life-threatening outcomes. Regulatory labels do not document any specific systemic symptoms, clinical signs, or associated laboratory abnormalities following ingestion of excessive amounts.

Despite this low inherent toxic risk, official government guidance mandates a strict emergency action protocol for any accidental overdose. The regulatory instruction explicitly requires that users get medical help and contact a Poison Control Center immediately. This immediate action is necessary to ensure medical assessment, even if the person appears asymptomatic or if no signs of distress are apparent. This is the primary help-seeking trigger defined by regulatory authorities.

Management and Monitoring

In line with the lack of systemic toxicity, no specific antidote is known or required for Simethicone overdose. Supportive management, which may include observation and appropriate administration of fluids, can be considered. Regulatory labels contain no documented notes regarding increased overdose severity for specific populations, such as children, the elderly, or those with underlying hepatic or renal impairment.

Therapeutic Uses of Simecrin

What Simecrin Treats: Main Uses and Benefits

Simecrin is considered relevant to help with symptoms related to physical discomfort and increased tension from gas in the digestive system. The medication may be applied across therapeutic domains where additional symptomatic support is needed. The primary therapeutic applications include relief from bloating, abdominal fullness, discomfort, and pressure.

The medication may be applied in conditions associated with recurrent or episodic manifestations, such as aerophagia and meteorism. It is relevant for easing symptoms linked to conditions where functional stability becomes affected, offering supportive therapeutic relief. The medicine may assist with supportive relief when symptoms interfere with routine activities.

It is often used during phases when symptoms become more noticeable, which may contribute to day-to-day comfort. This helps patients cope more steadily with symptom fluctuations and supports general well-being during symptomatic phases.


Quick Fact: Support for Gas-Related Symptoms


Regulatory References

  1. NIH MedlinePlus overview on Simethicone

Eligibility and Restrictions for Use

Who Can and Cannot Use Simecrin?

The population eligibility for Simecrin (Simethicone) is strictly defined by regulatory documents based on the drug's physical, non-absorbed mechanism of action. The medicine is contraindicated and must not be used by individuals with a known hypersensitivity to the ingredients or by those with suspected or confirmed gastrointestinal obstruction or intestinal perforation.

Age-Group Eligibility

Population Eligibility Status Regulatory Consideration
Adults & Adolescents Established Use Standard labeled conditions.
Infants & Children Established, but Conditional Use in children under 12 may require medical supervision, and use for infant colic is not universally recommended.
Older Adults Established Use No specific dose restriction is typically noted.

Physiological State & Comorbidities

Simethicone is permitted during pregnancy and breastfeeding because the active ingredient is not absorbed systemically and is not transferred to breast milk. Due to this non-systemic nature, no specific restrictions are placed on patients with renal or hepatic impairment. A conditional restriction applies to patients with Phenylketonuria (PKU), who must avoid specific formulations that contain phenylalanine.

What should I know about interactions with other medicines?

Simecrin Interactions with other medicines and products

Simecrin (which contains the active ingredient simethicone) is generally considered to have a low potential for drug interactions because it is not absorbed into the bloodstream. However, it is essential to be aware of certain interactions that can affect the absorption of other medications within the digestive tract.


Medications for Thyroid Conditions

Simecrin may interfere with the proper absorption of levothyroxine and other thyroid medications (such as liothyronine, liotrix, and desiccated thyroid). This interaction can potentially reduce the effectiveness of the thyroid medication. To minimize this effect, patients should separate the dosing of Simecrin from their thyroid medication by at least four hours.


Other Potential Interactions

Although less common, case reports suggest potential altered absorption of other medications, including carbamazepine. If Simecrin is used in a combination product (e.g., with antacids or activated charcoal), the potential for interactions is higher, as the added ingredients may interact with numerous other drugs. Always consult a healthcare provider before starting Simecrin if you are taking any other prescription, over-the-counter (OTC) medicines, or dietary supplements.

Mechanism of Action

How Simecrin Works: Mechanism of Action

Simecrin acts as a purely physical gastrointestinal agent. The mechanism is physically non-systemic, distinguishing it from those involving systemic absorption or biochemical signaling. The core of its action is the modulation of surface tension within the gut lumen, not the modulation of biological targets like receptors or enzymes.


Physical-Chemical Targeting of Intraluminal Surface Tension

The primary mechanism involves the compound Simethicone intervening at the gas-liquid interface of the gut contents. It functions as a surfactant to decrease the surface tension of the stabilizing film (often mucus or protein) surrounding small, trapped gas bubbles. This physical-chemical action is the first step in the mechanistic cascade, distinguishing it from agents that modulate neural or humoral pathways.


Mechanistic Cascade of Gas Coalescence and Alteration of Local Force

By lowering the surface tension, the compound initiates a defoaming cascade where numerous small, stable gas micro-bubbles coalesce into fewer, larger volumes of free gas. This shift from a stable foam suspension to free gas facilitates the physical passage or passive absorption of the gas. The resulting physiological effect is the alteration of localized physical force dynamics within the intestinal walls.

Dosage and Administration Information

How to use Simecrin

Simecrin is administered exclusively via the oral route across all commercially available forms, which include capsules, chewable tablets, and liquid oral suspension. The medicine is used on an as-needed (PRN) basis for symptomatic relief, following a frequency pattern of up to four times daily. Official administration instructions emphasize taking the dose after meals and at bedtime to align with digestive activity.


Labeled Dosing and Administration Rules

Dosing is strictly defined by age and is subject to a maximum daily limit:

  • Adults and Adolescents (12+): Typical single dose ranges from 40 mg to 125 mg, with the maximum daily intake constrained not to exceed 500 mg in 24 hours.
  • Pediatric Use (2–12 years): 40 mg per dose, not to exceed 480 mg daily.
  • Infants (Under 2 years): 20 mg per dose, not to exceed 240 mg daily.

Correct preparation is vital for efficacy, based on the dosage form:

  • Chewable tablets must be chewed thoroughly before swallowing.
  • Liquid suspensions must be shaken well and measured precisely using the provided dropper, and may be mixed with a small amount of water or formula to facilitate intake.
  • Liquid-filled capsules must always be swallowed whole with water.

This medicine is also used as a single, higher dose prior to certain abdominal imaging procedures to clear gas interference, representing a special procedural condition of use.

Recent Clinical Evidence

Research evidence / Overview of Studies for Simecrin


Evidence for Symptomatic Relief of Gas and Bloating

Research has explored Simecrin in studies examining patient-reported outcomes describing perceived discomfort related to gas and bloating. Research primarily includes short-term Randomized Controlled Trials (RCTs) and systematic reviews. These studies included general adult populations who reported symptoms of bloating, abdominal fullness, and pressure. Researchers examined patient-reported outcomes describing perceived discomfort using various scoring systems to monitor changes in the frequency and intensity of symptoms during the defined study intervals.

Studies report patterns related to outcomes describing episodic or acute changes measured during trials comparing Simecrin to a placebo (an inactive substance). However, research involving conditions with outcomes related to systemic or functional imbalance (such as certain functional bowel disorders) often encountered mixed findings, indicating that the evidence quality varies across studies when Simecrin was evaluated in these more complex contexts.

Long-term effects are not fully established regarding the consistent use of Simecrin for chronic or frequently recurring gas symptoms. The follow-up durations were limited in most key studies. Research provides context but not individual predictions. Long-term data about the durability of observed symptom patterns over many months or years remain limited.


Evidence for Procedural Use in Diagnostic Imaging

Simecrin was studied for a distinct purpose in research exploring temporary physiological imbalance: evaluating its effect on the ability to see the lining of the digestive tract during internal diagnostic procedures like colonoscopy or gastroscopy. Short-term RCTs and several meta-analyses examined the physical action of the medicine. The studies monitored outcomes related to the reduction of foam and air bubbles that can obscure the view, using standardized bubble scoring systems.

Studies report patterns related to measurements showing a reported decrease in the physical presence of air bubbles and foam following administration in preparation solutions. The specific clinical impact of these physical outcomes related to visualization on long-term patient outcomes is not typically the focus of these short-term procedural studies.


Studies in Special Patient Populations

Simecrin was evaluated in specific demographic groups, most notably infants and older adults. Research has explored its use in infants for symptoms associated with infantile colic, but findings were mixed across multiple systematic reviews. Studies monitored the use of Simecrin in older adults, often those experiencing functional symptoms, contributing to the broader evidence base for outcomes related to physical discomfort.

Key Studies & References

  1. Simethicone - StatPearls - NCBI Bookshelf
  2. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans in patients with irritable bowel syndrome

Frequently Asked Questions (FAQ)

Common questions about Simecrin (FAQ)


Q: What is the main difference between Simecrin and other common treatments for the same condition?

Regulatory documents describe Simecrin as a physical-chemical agent, meaning it acts only within the gut to address trapped gas. A key distinction is that the active ingredient, Simethicone, is not absorbed into the bloodstream or the body’s systems, unlike some other treatments.

Q: Is Simecrin considered a long-term or short-term treatment?

Official uses describe the product for symptomatic relief to be used on an as-needed (PRN) basis after meals and at bedtime. While many people use it periodically, studies examining the effects of very long-term, continuous use have generally been limited in duration.

Q: What does 'contraindication' mean in relation to Simecrin?

A contraindication refers to a condition or situation that makes the use of a medicine improper or potentially harmful. For Simecrin, regulatory labels state that it must not be used if you have a known hypersensitivity (an allergic reaction) to any of its ingredients.

Q: What are the typical ingredients found in Simecrin?

The active ingredient is Simethicone. Official labels and regulatory information for different product forms list various inactive ingredients, or excipients, which may include components like gelatin, sorbitol, cellulose, or coloring agents.

Q: If I feel better, is it okay to stop taking Simecrin before finishing the full course?

The medicine is described in official product information for use as needed for the relief of symptoms (PRN use), rather than as a scheduled, fixed course of treatment. This means it is typically used only when relief is required.

Q: Are there any known interactions between Simecrin and herbal supplements?

Regulatory sources generally advise that if the product is used in combination with dietary supplements or herbal remedies, a health professional should be consulted. While the interaction potential is low due to non-absorption, this consultation can provide context for safe use alongside all other products.

Q: How long does Simecrin stay in the body after the last dose?

Because Simecrin is a non-systemic agent that is not absorbed into the bloodstream, it remains only in the digestive tract. The compound then passes naturally through the system and is excreted unchanged in the feces.

Q: Why is Simecrin sometimes prescribed with other medications?

Regulatory documents list its use as an aid in the preparation for diagnostic procedures, such as colonoscopy or abdominal imaging. In this context, it is used to reduce gas and foam bubbles, often alongside other preparation solutions.

Q: Can Simecrin be taken if I am already taking over-the-counter pain relievers?

Official drug labels do not generally list an interaction with common over-the-counter pain relievers. However, regulatory sources emphasize the need to consult a healthcare professional about all concurrent medications, including OTC products, before use.

Q: Is it possible to become dependent on Simecrin if it's used for an extended period?

Regulatory documents classify Simecrin as Not a controlled medication. Its mechanism is physically non-systemic, meaning it does not act on the central nervous system or biological targets typically associated with the development of physical dependence.

Q: What happens if I accidentally miss a dose of Simecrin?

As the medicine is primarily used as-needed for symptom relief, official instructions do not typically include specific guidance for recovering a missed dose in the way a maintenance medication would. Official information on its administration describes use continuing as needed for symptomatic relief, provided the maximum labeled daily amount is not exceeded.

Q: Does Simecrin affect my ability to drive or operate machinery?

Due to its non-systemic mechanism of action, which prevents absorption into the bloodstream, official labels generally do not include specific warnings about impairment of the ability to drive or operate machinery.

Q: What happens if I take more Simecrin than the amount described in the leaflet?

Official labels include an overdose warning emphasizing that taking more than the maximum amount is not advised. The warning describes the need to contact emergency medical help or a Poison Control Center if the maximum dose has been exceeded.

Q: Can Simecrin interact with birth control pills?

Drug labels generally do not list a specific interaction with oral contraceptives. However, general cautionary statements advise discussing all concurrent medications, including birth control, with a health professional.

Q: Is it normal to feel slightly dizzy or lightheaded after starting Simecrin?

Dizziness or lightheadedness is not listed among the documented adverse reactions found in official regulatory documents. Official product information emphasizes that severe or unexpected reactions should be brought to the attention of a healthcare professional.

Q: Does the color or shape of the Simecrin pill have any meaning?

Official labels describe the color and shape as product characteristics defined by the manufacturer for product identification. These characteristics may vary between brands or forms but do not change the active ingredient or its intended purpose.

Q: If I have allergies to other medications, can I still take Simecrin?

Official documents only contraindicate use for a known hypersensitivity to Simecrin ingredients. However, as a precaution, regulatory guidance advises consulting a healthcare professional about all allergies to other medicines before taking Simecrin.

Q: Can Simecrin be taken with alcohol?

Official drug labels do not typically include a specific warning or contraindication against the simultaneous use of alcohol with Simecrin.

Q: What are the main risks associated with stopping Simecrin abruptly?

Due to its use as-needed (PRN) for symptomatic relief and its non-systemic action, official documents do not list specific risks or adverse effects associated with abruptly stopping the medicine.

Q: Are there generic versions of Simecrin available?

Regulatory-sourced information confirms that many generic versions containing the active ingredient Simethicone are widely available as over-the-counter products for gas relief.

Q: Does taking Simecrin cause weight gain or loss?

Weight gain or loss is not listed among the documented adverse reactions found in official regulatory documents for Simecrin.

Q: Can Simecrin be used by vegetarians or vegans?

While the active ingredient is generally compatible, some specific formulations (e.g., soft-gel capsules) may contain ingredients like gelatin, which is not vegetarian or vegan. Regulatory labels list these inactive ingredients (excipients) for review.

Q: Does Simecrin have any effect on blood pressure or heart rate?

Due to its non-systemic and purely physical mechanism, regulatory documents do not list effects on blood pressure or heart rate in the side effects or mechanism sections, as it is not absorbed into the body’s circulatory system.

How should Simecrin be stored and disposed of?

Storage and Disposal of Simecrin

Simecrin (Simethicone) must be stored and handled according to specific conditions mandated by regulatory labeling to maintain its stability.

Storage Requirements

  • Temperature Control: Store the medicine at controlled room temperature, typically between 20°C and 25°C (68°F and 77°F). Some labels specify storage below 30°C.
  • Environmental Protection: The product must be protected from light, heat, and moisture. Liquid formulations often carry the instruction: do not freeze.
  • Container and Safety: Keep the medication in its original package and ensure the container is tightly closed. Keep the product out of the sight and reach of children.
  • Stability: The medicine must not be used after the expiry date indicated on the package.

Disposal Instructions

Unused or expired product should not be disposed of via household waste or wastewater. Disposal must be carried out in accordance with local requirements to protect the environment. A pharmacist can provide guidance on safe disposal procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Simecrin found in:

A-Z Index: